Professional Summary

Professional Overview

Lisa Molz is an accomplished pharmaceutical industry leader currently serving as the VP of Research at Avilar Therapeutics. With over two decades of experience in drug discovery and development, she brings a wealth of expertise in the research and advancement of innovative therapeutics.

Experience Summary

Current Role

In her current role as VP of Research at Avilar Therapeutics, Lisa is responsible for overseeing the company's comprehensive research program, leading cross-functional teams to drive the development of novel drug candidates. She plays a pivotal part in shaping Avilar's research strategy, ensuring the efficient translation of scientific discoveries into viable clinical-stage programs.

Career Progression

Prior to joining Avilar, Lisa held senior-level positions at various renowned pharmaceutical companies. As the Senior Director at Mitobridge, a wholly owned subsidiary of Astellas, she led a team of researchers in advancing mitochondrial-targeted therapies. Earlier in her career, she served as the Biology Director at Navitor Pharmaceuticals, where she made significant contributions to the company's pipeline of mTOR-modulating therapeutics. Lisa's extensive experience also includes roles as a Senior Scientist at FORMA Therapeutics, GPC Biotech, and Genetica.

Academic Background

Lisa holds a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology, where she specialized in the study of cellular signaling pathways and their implications for drug development. Her academic achievements include numerous publications in peer-reviewed journals and presentations at industry conferences.

Areas of Expertise

Throughout her career, Lisa has demonstrated expertise in various areas of pharmaceutical research and development, including target identification, lead optimization, preclinical studies, and early-stage clinical trial design. She is a skilled communicator and collaborator, adept at leading cross-functional teams and fostering productive partnerships with academic and industry partners.

Professional Impact

Lisa's work has contributed to the advancement of several drug candidates, with two programs successfully reaching late-stage clinical trials under her leadership. Her industry contributions have been recognized through awards and invitations to speak at prestigious industry events, where she shares her insights and experiences to inspire and guide the next generation of pharmaceutical researchers.

Conclusion

With her exceptional track record in pharmaceutical research, Lisa Molz is poised to continue driving transformative advancements in the development of cutting-edge therapeutics at Avilar Therapeutics. Her strong technical expertise, strategic vision, and collaborative leadership style make her a valuable asset in the pursuit of innovative solutions to address unmet medical needs.